Literature DB >> 21535168

The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo.

Jeong Eun Do1, Jae Yong Shin, Do-Young Kim, Seung-Kyung Hann, Sang Ho Oh.   

Abstract

BACKGROUND: Segmental vitiligo (SV), which frequently accompanies poliosis, indicating a poor prognosis that is likely resistant to treatments.
OBJECTIVES: In this study, we performed a retrospective analysis to evaluate the treatment response to 308 nm excimer laser in SV patients.
METHODS: A retrospective chart and photographic review was performed on 80 SV patients who had been treated with 308nm excimer laser for >3 months.
RESULTS: Eighty patients with SV (mean age: 24.0 years ± 15.3, males: 50%) were included in this study. The mean grade of repigmentation was 2.3 after 20.6 months of mean treatment duration; 23.8% of 80 patients showed grade 4, 20% showed grade 3, and 56.2% showed grade 1-2 repigmentation. However, none of them achieved complete repigmentation with excimer laser. The degree of repigmentation was positively correlated with treatment duration (r=0.315, P=0.004) and cumulative ultraviolet (UV) dosage (r=0.366, P=0.001), whereas it was negatively correlated with disease duration (r=-0.265, P=0.017).
CONCLUSION: This study suggests that SV has a better repigmentation response when excimer laser is used at earlier stages of the disease and long-term use and high cumulative UV energy of the excimer laser elicit better responses. Additional treatments like surgical procedures in addition to excimer laser should be considered for complete repigmentation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21535168     DOI: 10.1111/j.1600-0781.2011.00587.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  7 in total

1.  Contextual DNA features significant for the DNA damage by the 193-nm ultraviolet laser beam.

Authors:  N N Vtyurina; S L Grohovsky; A B Vasiliev; I I Titov; P M Ponomarenko; M P Ponomarenko; S E Peltek; Yu D Nechipurenko; N A Kolchanov
Journal:  Dokl Biochem Biophys       Date:  2013-01-04       Impact factor: 0.788

Review 2.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

3.  Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

Authors:  Lu-Mei Wang; Wan-Jiao Lu; Jing-Tao Yuan; Bi-Bing Zeng; Dan Li; Feng Zhang; Jun-Jie Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

4.  A Retrospective Study of 3,000 Indian Patients with Vitiligo Treated with Phototherapy or Topical Monotherapy.

Authors:  Jagdish Sakhiya; Dhruv Sakhiya; Neha Virmani; Trusha Gajjar; Jitesh Kaklotar; Ravi Khambhati; Feral Daruwala; Nimish Dudhatra
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

5.  Granuloma annulare treated with excimer laser.

Authors:  Roman Bronfenbrener; Jennifer Ragi; Sandy Milgraum
Journal:  J Clin Aesthet Dermatol       Date:  2012-11

6.  Expression of Epidermal c-Kit+ of Vitiligo Lesions Is Related to Responses to Excimer Laser.

Authors:  Oun Jae Park; Ji Su Han; Sang Hyung Lee; Chan-Sik Park; Chong Hyun Won; Mi Woo Lee; Jee Ho Choi; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

Review 7.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.